Table 1.
Baseline Characteristics and Inflammatory Parameters of All Subjects [mean ± SD, M(IQR)]
| Parameter | Healthy groups | Psoriasis groups | t/χ2 | P |
|---|---|---|---|---|
| N | 40 | 45 | - | - |
| Age (year) | 36.000 ± 8.659 | 37.667 ± 9.535 | –0.840 | 0.403 |
| Men (%) | 47.500 | 53.300 | 0.288 | 0.591 |
| Duration (year) | 0.000 (0.000) | 6.000 (7.500) | 8.387 | < 0.001 |
| PASI | 0.000 (0.000) | 19.500 (11.900) | –13.871 | < 0.001 |
| Leukocytes (× 109/L) | 6.798 ± 2.064 | 7.030 (3.410) | 1.985 | 0.047 |
| Neutrophil (× 109/L) | 4.566 ± 1.951 | 4.920 (3.140) | 2.157 | 0.031 |
| Lymphocytes (× 109/L) | 1.946 ± 0.520 | 1.947 ± 0.540 | –0.007 | 0.994 |
| Platelets (× 109/L) | 235 ± 60 | 235 (189) | 1.444 | 0.149 |
| ESR (mm/h) | 11 (6) | 30 (63) | 4.949 | < 0.001 |
| CRP (mg/L) | 5.740 (5.530) | 18.560 (43.645) | 5.212 | < 0.001 |
| NLR | 2.105 (1.416) | 3.440 (1.670) | 5.115 | < 0.001 |
| PLR | 127.941 ± 43.173 | 144.630 (96.175) | 1.259 | 0.208 |
NLR neutrophil-to-lymphocyte ratio, PASI Psoriasis Area and Severity Index, PLR platelet-to-lymphocyte ratio